Febuxostat Tablet, Film Coated
Product Images NDC 71610-411

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Febuxostat (NDC 71610-411). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 40 mg (71610 0411 60)

Label for Febuxostat film-coated tablets, 40 mg strength, NDC 71610-411. The label indicates the product is for oral use and prescription only. It includes storage instructions to keep the tablets at 20-25 degrees Celsius and to dispense in a tight light-resistant container. The label also notes the manufacturer as MFG BY: CPL Laboratories Private Limited and the packager as Aphena Pharma Solutions - Tennessee, LLC in Cookeville, TN.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Febu-str (Febuxostat Structure)

Chemical structure of Febuxostat, showing its molecular arrangement including functional groups such as an isobutoxy group, cyano group, thiazole ring, and carboxylic acid with a water molecule hydrate.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.